Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 2529 entries
View as:

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02487498 Org: User:
Start: 07/27/15 End: 09/06/16 Due: 09/06/17

A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01730248 Org: User:
Start: 12/18/12 End: 09/28/17 Due: 09/28/18

Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01147822 Org: User:
Start: 05/19/10 End: 09/03/21 Due: 09/03/22

Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04074590 Org: User:
Start: 02/03/20 End: 11/07/22 Due: 11/07/23

A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06431763 Org: User:
Start: 06/21/24 End: 09/30/25 Due: 09/30/26

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04699188 Org: User:
Start: 02/24/21 End: 08/26/26 Due: 08/26/27

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT05648968 Org: User:
Start: 12/30/22 End: 05/02/29 Due: 05/02/30

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Phase: N/A Priority: Normal
NCT ID: NCT00061763 Org: User:
Start: 05/31/03 End: - Due: -

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Phase: N/A Priority: Normal
NCT ID: NCT06401356 Org: User:
Start: 08/13/24 End: 06/30/27 Due: 06/30/28

Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04896632 Org: User:
Start: 05/13/21 End: 11/24/22 Due: 11/24/23

EXPLAIN -FragilE X Registry: An exPlorative Longitudinal Study for chAracterIzation, Treatment Pathways and patieNt-related Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01711606 Org: User:
Start: 03/31/13 End: 01/31/16 Due: 01/31/17

Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Phase: N/A Priority: Normal
NCT ID: NCT02980263 Org: User:
Start: 11/15/16 End: 11/30/17 Due: 11/30/18

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00170846 Org: User:
Start: 02/28/05 End: 10/31/09 Due: 10/31/10

Safety and Tolerability of Oral LCL161 in Japanese Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01968915 Org: User:
Start: 11/30/13 End: 06/30/15 Due: 06/30/16

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03905525 Org: User:
Start: 10/01/19 End: 06/06/23 Due: 06/06/24

Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00768040 Org: User:
Start: 09/30/08 End: 02/28/11 Due: 02/28/12

Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa

Phase: N/A Priority: Normal
NCT ID: NCT02248922 Org: User:
Start: 01/27/15 End: 04/10/17 Due: 04/10/18

Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT01785602 Org: User:
Start: 06/30/13 End: 11/30/14 Due: 11/30/15

Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01172548 Org: User:
Start: 08/31/08 End: 03/31/14 Due: 03/31/15

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Phase: N/A Priority: Normal
NCT ID: NCT01368523 Org: User:
Start: 12/31/08 End: - Due: -

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02333370 Org: User:
Start: 02/04/15 End: 09/29/22 Due: 09/29/23

Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.

Phase: N/A Priority: Normal
NCT ID: NCT05448872 Org: User:
Start: 11/23/20 End: 09/15/21 Due: 09/15/22

Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT03328897 Org: User:
Start: 04/26/17 End: 09/24/19 Due: 09/24/20

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01602315 Org: User:
Start: 11/12/12 End: 09/16/16 Due: 09/16/17

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00239876 Org: User:
Start: 05/31/05 End: - Due: -